International Ophthalmology

, Volume 31, Issue 6, pp 461–465

The role of serology in active ocular toxoplasmosis

Original Paper


Our purpose was to examine toxoplasmic serology in relation to episodes of suspected acute toxoplasmic retinochoroiditis and evaluate its use in the appraisal of patients. The mean values of enzymatic immunoassay (EIA) titers for toxoplasmic antibodies were retrospectively compared in patients with active and inactive toxoplasmosis and in a third group of uveitis cases not caused by toxoplasmosis. The proportion of cases under and above a predefined serology value above cut-off was compared in all groups. Between 1995 and 2010, 97 out of 1,276 new uveitis cases seen at the Centre for Ophthalmic Specialized Care (COS), Lausanne, Switzerland were diagnosed as toxoplasmic retinochoroiditis, of which 51 had documented serology available. The mean EIA values for immunoglobulin (Ig) G were 147.75 ± 259.4 IU/ml for patients with active disease, 18.93 ± 23.09 (p < 0.05) for patients with inactive toxoplasmosis and 18.35 ± 20.82 for controls (p < 0.017). The proportion of cases under the designated limit value were 2/51 (4%) in the active retinitinochoroiditis group, 14/27 (52%) (p < 0.05) in the control group, and 7/7 (100%) in the inactive toxoplasmic group (p < 0.001). Three out of 51 cases showed high IgM values in addition to IgG elevation and were primary infections. Toxoplasmosis serology, contrary to popular belief, is useful to confirm active toxoplasmic retinochoroiditis; it is easy to perform, cheap and supports clinical diagnosis in up to 96% of cases, not only by showing positivity but by also showing a significant elevation of titers. In atypical cases serology is not only useful but essential.


Serology Toxoplasmic retinochoroiditis Active disease Atypical cases 


  1. 1.
    Commodaro AG, Belfort RN, Rizzo LV et al (2009) Ocular toxoplasmosis: an update and review of the literature. Mem Inst Oswaldo Cruz 104(2):345–350PubMedCrossRefGoogle Scholar
  2. 2.
    Munio JC, Juarez CP, Luna JD et al (1999) The importance of specific IgG and IgE autoantibodies to retinal S antigen, total serum IgE, and sCD23 levels in autoimmune and infectious uveitis. J Clin Immunol 19(4):215–222CrossRefGoogle Scholar
  3. 3.
    Pleyer U, Torun N, Liesenfield O (2007) Ocular toxoplasmosis. Ophthalmologe 104(7):603–615PubMedCrossRefGoogle Scholar
  4. 4.
    Ongkosuwito JV, Bosch-Driessen EH, Kijlstra A, Rothova A (1999) Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol 128(4):407–412PubMedCrossRefGoogle Scholar
  5. 5.
    Holland GN (1999) Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 128(4):502–505PubMedCrossRefGoogle Scholar
  6. 6.
    Silveira C, Belfort R Jr, Burnier M Jr et al (1998) Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol 106(3):362–364Google Scholar
  7. 7.
    Bonfioli AA, Orefice F (2005) Toxoplasmois. Semin Ophthalmol 20(3):129–141PubMedCrossRefGoogle Scholar
  8. 8.
    Berthoud Kündig JF, Keller A, Herbort CP (1994) Increase in polyclonal immunoglobulins: a possible useful aid in diagnosis of uveitis caused by sarcoidosis. Klin Monbl Augenheilkd 204(5):323–329PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Centre for Ophthalmic Specialized Care (COS)LausanneSwitzerland
  2. 2.Eye Clinic, Department of Neurosciences, Ophthalmology and GeneticsUniversity of GenovaGenovaItaly
  3. 3.Head and Neck Department, Section of OphthalmologyUniversity of ParmaParmaItaly
  4. 4.University of LausanneLausanneSwitzerland

Personalised recommendations